减少亚洲低剂量CT肺癌筛查过度诊断的实用策略
该回顾性队列研究纳入2006年1月至2021年12月506例≤3cm亚实性结节患者,比较直接LDCT筛查与LDCT联合胸片分诊两组。倾向性评分匹配后194例分析,直接LDCT组37.1%切除病灶为原位腺癌或不典型腺瘤样增生,胸片分诊组无此类病灶,两组无病生存与复发率无显著差异。
要点
- 胸片分诊组无原位腺癌/不典型腺瘤样增生病灶,直接LDCT组为37.1%。
- 匹配后两组无病生存与复发率无显著差异,15年生存率均高。
- 年龄、性别、结节大小、吸烟状态、筛查方法均非死亡显著预测因子。
核心结论
- 胸片分诊可作为亚洲非吸烟高危人群LDCT肺癌筛查的初步步骤,以减少不必要手术并保持诊断有效性;需进一步前瞻性多中心研究验证其长期安全性、成本效益和常规临床可接受性。
研究设计与样本
- 回顾性队列研究,纳入2006年1月至2021年12月506例≤3cm亚实性结节患者,比较直接LDCT筛查组与LDCT联合胸片分诊组;胸片分诊组为3个月内同时接受LDCT和胸片且胸片可见结节经手术病理确认者;采用年龄、性别、结节大小进行1:1倾向性评分匹配,得97对匹配(194例)用于结局比较。
关键影像表现/征象
- 直接LDCT组切除病灶中37.1%为原位腺癌或不典型腺瘤样增生,胸片分诊组无此类病灶,差异显著。
- 匹配后随访期间两组无病生存率与复发率无显著差异。
- 15年Kaplan-Meier生存分析显示两组生存率均高且无显著差异。
诊断标准与关键数值
- 过度诊断评估指标为切除病灶中原位腺癌或不典型腺瘤样增生的比例,直接LDCT组37.1%,胸片分诊组0%。
- 多因素Cox回归显示年龄、性别、结节大小、吸烟状态和筛查方法均非死亡的显著预测因子。
临床应用与阅片要点
- 对亚洲非吸烟高危人群LDCT筛查中≤3cm亚实性结节,可考虑先以胸片分诊作为初步步骤(作者结论)。
- 胸片分诊组仅纳入胸片可见且经手术病理确认的结节,阅片时需注意该选择条件。
局限性
- 原文为回顾性队列研究。
- 需进一步前瞻性多中心研究验证长期安全性、成本效益和常规临床可接受性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Low-dose computed tomography (LDCT) screening reduces lung cancer mortality but may lead to overdiagnosis and overtreatment, especially among the Asian LDCT screening population presenting with subsolid nodules (SSNs). Thus, we explored whether implementing chest X-ray (CXR) triage as a preliminary screening tool can improve patient selection and reduce unnecessary interventions.
MATERIALS AND METHODS: This retrospective cohort study compared patients who underwent direct LDCT screening with those who underwent LDCT and CXR triage. Medical records of 506 patients with SSNs ≤3cm from January 2006 to December 2021 were reviewed. Primary outcomes included lung cancer prognosis, relapse, and histopathologic spectrum of lung adenocarcinoma to assess potential overdiagnosis. The CXR triage group consisted of patients who had both LDCT and CXR within 3 months, with CXR-visible nodules confirmed by surgical pathology. A 1:1 propensity score matching (PSM) was performed using age, sex, and nodule size, resulting in 97 matched pairs for balanced outcome comparison.
RESULTS: After PSM, 194 patients were analyzed. In the direct LDCT group, 37.1% of resected lesions were adenocarcinoma in situ (AIS) or atypical adenomatous hyperplasia (AAH), indicating a higher likelihood of overdiagnosis. Conversely, the CXR triage group had no patients with AIS/AAH, a significant difference. No significant differences were observed in disease-free survival or relapse rates between groups during follow-up, suggesting that CXR triage may reduce overtreatment without negatively impacting short-term prognosis. Multivariate Cox regression revealed that age, sex, nodule size, smoking status, and screening method were not significant predictors of mortality. Kaplan-Meier survival analysis over 15 years showed similarly high survival rates in both groups, with no significant difference.
CONCLUSION: CXR triage is a preliminary step in LDCT screening for lung cancer, particularly in non-smoking Asian high-risk populations, to reduce unnecessary surgical procedures while preserving diagnostic effectiveness. Further prospective multicenter studies are needed to validate its long-term safety, cost-effectiveness, and acceptability in routine clinical practice.
引用
- Wu YJ, Hung YC, Tang EK, et al. Practical Strategy to Mitigate Overdiagnosis in Asian Low-dose Computed Tomography Lung Cancer Screening. Acad Radiol. 2025. PMID: 41102060. doi:10.1016/j.acra.2025.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。